AU7555591A - Inhibition of allograft and concordant xenograft rejection - Google Patents

Inhibition of allograft and concordant xenograft rejection

Info

Publication number
AU7555591A
AU7555591A AU75555/91A AU7555591A AU7555591A AU 7555591 A AU7555591 A AU 7555591A AU 75555/91 A AU75555/91 A AU 75555/91A AU 7555591 A AU7555591 A AU 7555591A AU 7555591 A AU7555591 A AU 7555591A
Authority
AU
Australia
Prior art keywords
allograft
inhibition
xenograft rejection
concordant xenograft
concordant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU75555/91A
Other languages
English (en)
Inventor
Johan Beyers Van Den Bogaerde
David James Graham White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imutran Ltd
Original Assignee
Imutran Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imutran Ltd filed Critical Imutran Ltd
Publication of AU7555591A publication Critical patent/AU7555591A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
AU75555/91A 1990-04-09 1991-04-04 Inhibition of allograft and concordant xenograft rejection Abandoned AU7555591A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909007971A GB9007971D0 (en) 1990-04-09 1990-04-09 Pharmaceutical formulations
GB9007971 1990-04-09

Publications (1)

Publication Number Publication Date
AU7555591A true AU7555591A (en) 1991-10-30

Family

ID=10674123

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75555/91A Abandoned AU7555591A (en) 1990-04-09 1991-04-04 Inhibition of allograft and concordant xenograft rejection

Country Status (22)

Country Link
EP (1) EP0527762B1 (enExample)
JP (1) JP3518547B2 (enExample)
CN (1) CN1040178C (enExample)
AT (1) ATE141167T1 (enExample)
AU (1) AU7555591A (enExample)
CZ (1) CZ283119B6 (enExample)
DE (1) DE69121401T2 (enExample)
DK (1) DK0527762T3 (enExample)
ES (1) ES2090325T3 (enExample)
GB (1) GB9007971D0 (enExample)
GR (1) GR3021642T3 (enExample)
HK (1) HK48597A (enExample)
IE (1) IE911153A1 (enExample)
IL (1) IL97788A (enExample)
IN (1) IN173149B (enExample)
MY (1) MY106158A (enExample)
NZ (1) NZ237739A (enExample)
PT (1) PT97277B (enExample)
SG (1) SG47465A1 (enExample)
SK (1) SK279949B6 (enExample)
WO (1) WO1991015221A1 (enExample)
ZA (1) ZA912467B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE297217T1 (de) 1999-10-27 2005-06-15 Alexandra Lucas Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
US7419670B2 (en) 2000-09-29 2008-09-02 Viron Therapeutics, Inc. Method of treating arthritis with SERP-1 and an immunosuppressant
EP2338511A3 (en) * 2004-05-14 2012-07-25 Alexion Pharmaceuticals, Inc. Prolongation of survival of an allograft by inhibiting complement activity
US7285530B2 (en) 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
LT3028716T (lt) 2006-10-10 2020-12-10 Regenesance B.V. Komplemento slopinimas nervų regeneracijos pagerinimui
JP6223659B2 (ja) 2008-11-10 2017-11-01 アレクシオン ファーマシューティカルズ， インコーポレイテッド 補体関連障害を処置するための方法および組成物
AU2014306002B2 (en) 2013-08-07 2017-05-25 Alexion Pharmaceuticals, Inc. Atypical hemolytic uremic syndrome (aHUS) biomarker proteins
WO2026064591A1 (en) * 2024-09-20 2026-03-26 Antinous Technology Company Limited Methods and compositions for preventing herpes virus reactivation in organ xenograft

Also Published As

Publication number Publication date
HK48597A (en) 1997-04-25
IL97788A (en) 1998-02-08
JPH05507266A (ja) 1993-10-21
IE911153A1 (en) 1991-10-09
DK0527762T3 (da) 1996-09-02
CN1056240A (zh) 1991-11-20
GR3021642T3 (en) 1997-02-28
SG47465A1 (en) 1998-04-17
IN173149B (enExample) 1994-02-19
GB9007971D0 (en) 1990-06-06
EP0527762A1 (en) 1993-02-24
PT97277B (pt) 1998-08-31
MY106158A (en) 1995-03-31
ZA912467B (en) 1992-12-30
CN1040178C (zh) 1998-10-14
EP0527762B1 (en) 1996-08-14
IL97788A0 (en) 1992-06-21
WO1991015221A1 (en) 1991-10-17
ATE141167T1 (de) 1996-08-15
JP3518547B2 (ja) 2004-04-12
CZ283119B6 (cs) 1998-01-14
NZ237739A (en) 1993-09-27
DE69121401T2 (de) 1996-12-12
ES2090325T3 (es) 1996-10-16
SK279949B6 (sk) 1999-06-11
CS9100988A2 (en) 1991-12-17
PT97277A (pt) 1992-01-31
DE69121401D1 (de) 1996-09-19

Similar Documents

Publication Publication Date Title
EP0163475A3 (en) Immunoregulation
USD304433S (en) Earring
CA2179627A1 (en) Mixtures of Dideoxy-Nucleosides and Hydroxycarbamide for Inhibiting Retroviral Spread
AU2061397A (en) Immunosuppressive compounds and methods
AU5696798A (en) Stent grafts containing purified submucosa
EP0401747A3 (en) Use of rapamycin and derivatives and prodrugs thereof in the manufacture of a medicament for inhibiting transplant rejection in mammals
AU2310484A (en) Suture rings for heart valves
AU3742895A (en) Novel compositions
AU1441895A (en) Mediators of chronic allograft rejection
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
AU6974294A (en) Release and mobilisation of haematopoietic cells
IL97788A0 (en) Inhibition of allograft and concordant xenograft rejection
CA2021788A1 (en) Cyclosporin derivatives
AU7404494A (en) Methods and compositions for preventing immune rejection of solid organ grafts
HU901516D0 (en) The use of s-adenosile-methionine in the treatment of pancreatitis, and in preventing the natural rejection of transplanted pancreas
CA2168447A1 (en) Compounds and methods for inhibition of hiv and related viruses
AU8216691A (en) Autobiotics and their use in eliminating nonself cells in vivo
CA2120731A1 (en) Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein
AU3779693A (en) Antibodies for and treatment to prevent or reduce the severity of xenograft rejection
AU1123001A (en) Compositions and methods for preventing and treating transplant rejection
CA2134413A1 (en) Use of Hydroxychloroquine for Treatment of Graft-Versus-Host Disease
AU5682594A (en) Low denier polybenzazole fibers and the preparation thereof
AU3279889A (en) 1-dimethylcarbamoyl-3-substituted-5-substituted-1h-1,2,4- triazoles
AU1325883A (en) Spiro-chroman-imidazolidine
PL284247A1 (en) Method for processing full blood, blood plasma and densified blood cells